news
Sanofi to invest USD 75 million in a new manufacturing facility in Vietnam
29 March 2013 | By Sanofi
“This new production and development center is the largest investment ever made by Sanofi in Vietnam..."
List view / Grid view
Sanofi
news
Sanofi and Transgene announce innovative long-term collaboration
25 March 2013 | By Sanofi
Creation of a new state-of-the-art industrial platform at Genzyme’s unit in Lyon...
news
Effect of Genzyme’s LEMTRADA maintained in patients beyond two-year pivotal MS studies
21 March 2013 | By Sanofi
Results from the first year of the extension study of LEMTRADA™ (alemtuzumab)...
news
Sanofi launches 2013 Patient Group Bursary Scheme
21 March 2013 | By Just:: Health PR
2013 Patient Group Bursary Scheme launched...
news
Sanofi and Regeneron report positive proof-of-concept data for Dupilumab
2 March 2013 | By Sanofi
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that pooled data from two Phase 1b trials with dupilumab (REGN668/SAR231893), an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting the alpha subunit of the interleukin 4 receptor (IL-4R alpha), were presented at the 71st Annual Meeting…
news
Genzyme receives company award from European Organisation for Rare Diseases
27 February 2013 | By Genzyme
Sanofi and its subsidiary Genzyme announced today that Genzyme has received a Company Award from EURORDIS...
news
Sanofi New Drug Application for Lixisenatide accepted for review by FDA
19 February 2013 | By Sanofi
Sanofi announced that the U.S. FDA has accepted for review a New Drug Application for lixisenatide...
news
ZALTRAP® (aflibercept) approved in the EU
5 February 2013 | By Sanofi
First and only agent to statistically significantly improve survival in combination with FOLFIRI chemotherapy after an oxaliplatin regimen...
news
Once-daily Lyxumia® (lixisenatide) approved for treatment of type 2 diabetes in Europe
4 February 2013 | By Sanofi
Sanofi portfolio expands to offer first once-a-day prandial GLP-1 receptor agonist...
news
Genzyme and Isis announce FDA approval of KYNAMRO™ injection for the treatment of HoFH
29 January 2013 | By Sanofi
“Today’s FDA approval of KYNAMRO is great news..."
news
Genzyme’s LEMTRADA™ application for MS accepted for review by the FDA
28 January 2013 | By Sanofi
Genzyme also reports very encouraging early launch indicators for AUBAGIO® (teriflunomide) in U.S.
news
Auvi-Q™ is now available in the U.S.
28 January 2013 | By Sanofi
Auvi-Q is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions...
news
Sanofi provides an update on its research & development pipeline
8 January 2013 | By Sanofi
Sanofi will provide an update on its Research & Development (R&D) pipeline...
news
Sanofi appoints Dr. Gary J. Nabel as Chairman of the SDSAC
7 January 2013 | By Sanofi
“I am delighted that Dr. Gary Nabel will continue to make this Council a vital part of our efforts..."
news
Sanofi President, Global Operations, to retire
18 December 2012 | By Sanofi
Sanofi announced that Hanspeter Spek, President, Global Operations, will retire from his current role in mid-2013...
